Vapour from glo™ had little or no biological impact on cells in laboratory tests

Quick Navigation

Jump to content Logo
Vapour from glo™ had little or no biological impact on cells in laboratory tests
News release

25 October 2017

New research reveals that unlike cigarette smoke, vapour from the tobacco heating product (THP) glo™, has little or no biological effect on cells.

  • Unlike smoke, vapour from tobacco heating product - gloTM - is not toxic, does not cause oxidative stress, gene mutations or the promotion of tumours in cells in laboratory tests
  • glo™, a tobacco heating device, heats rather than burns tobacco
  • It is well established that it is the toxicants produced by burning tobacco that are responsible for causing most smoking-related diseases
  • The numbers and levels of toxicants in gloTM emissions are significantly lower than in cigarette smoke, meaning it has the potential to be reduced risk

THPs, like glo™, heat rather than burn tobacco and so have reduced numbers and levels of toxicants in emissions compared to cigarette smoke and therefore have the potential to be much less harmful.

Scientists at British American Tobacco conducted a range of tests comparing the impact of cigarette smoke with that of glo™ vapour on cells in the lab.

Cigarette smoke produced a clear response in all the tests used, confirming smoke is toxic and reduces cell viability, causes oxidative stress, gene mutations and the promotion of tumours. In contrast, the vapour produced by glo™, failed to elicit a response at doses equivalent to or higher than the cigarette smoke, demonstrating it is not toxic and doesn’t cause mutations.

‘We have produced a comprehensive suite of scientific tests and data, that clearly demonstrates that glo™ has lower biological activity compared to cigarette smoke,” said Dr James Murphy, Head of Reduced Risk Substantiation at British American Tobacco.  ‘glo™ induced either no or marginal responses in all tests conducted,’ he said.  ‘This comprehensive assessment is part of a science-based approach that we have developed to assess the reduced-risk potential of THPs and other next generation products relative to smoking cigarettes.  We believe that such an approach is essential to communicating to consumers and regulators that the available information on our products is based on sound, evidence-based science,’ he says.

How the Tests were done

Puffing robots were used in the lab to produce smoke and vapour. Cells, including human cells, were then exposed to the smoke and vapour and the impact on the cells compared to the impact of air.

Cell Viability – How Healthy are the cells?

The cells tested included human airway cells.  These are obtained by taking a sample from a human nose.  The cells are placed in a chamber that allows them to be nourished from the underside and exposed to air or vapour or smoke on the other side – much like cells are exposed to aerosols in the lung.

The health (viability) of the lung cells was tested by observing how effectively they can absorb a special red dye.  Healthy cells are very good at incorporating the dye into their structures and so appear red (Figure 1).  Unhealthy cells lose the ability to take up the dye and so change in colour from red to light pink (Figure 2).

Cells exposed to smoke got lighter in colour as the cells lost the ability to adsorb the red dye. In contrast, glo™ vapour remains red in colour, indicating that the vapour is substantially less toxic to cells. When all the cells exposed to smoke had died, those exposed to glo™ vapour were still 97% viable.

Genetic Mutations and tumour promotion

In other tests, bacteria were used to determine whether smoke or vapour causes mutations in DNA – the cell’s genetic material.  Mutations in genetic material are important because they could be involved in the development of cancer.

Scientists exposed special strains of bacteria to smoke or vapour and then observed whether there were any changes to the bacteria’s DNA.

Exposure to smoke caused mutations in a dose-dependent manner - the higher the dose, the higher the mutation rate.  Exposure to glo™ vapour did not cause any mutations, even after hours of continuous exposure, comparable to the results obtained when cells were exposed to air.

In other tests, the ability of vapour from glo™ to cause the development of tumours was compared to that of cigarettes.  

Results show that even at very low doses, cigarette smoke caused tumour-promotion whereas glo™ vapour did not.

Many tests at once: A method called ‘high-content-screening’ was used to test different aspects of the impact of smoke or vapour on human lung cells at the same time.

Fluorescent dye molecules are attached to different parts of the cell structure, allowing scientists to observe any changes in the cell structure or function. Cigarette smoke was positive in all tests. But comparable doses of glo™ vapour showed little or no activity, suggesting it is substantially less toxic to cells.

Taken together, the results of all these tests form the basis of a comprehensive dossier of scientific data that lay the groundwork for establishing this product’s reduced-risk potential compared to cigarettes.

The results are published today as part of a special issue of the journal Regulatory Toxicology and Pharmacology 

Figure 1. The Neutral Red assay uses a dye that healthy cells will take up becoming red in colour

Figure 2. Neutral Red assay results displaying colour change – Cells on the left have been exposed to gloTM vapour and retain the ability to incorporate the red dye. Cells on the right have been exposed to cigarettes smoke and do not retain the ability to incorporate the red dye.



Press Office
+44 (0) 20 7845 2888 (24 hours)